Sign up Australia
Proactive Investors - Run By Investors For Investors
Why invest in CLSU?

ClearStar thriving in the gig economy

A flexible jobs market, an increase in short-term contracts - all play to the strengths of the specialist in background checks
Jobs market
The company is now winning larger contracts

ClearStar Inc (LON:CLSU) is set to be a beneficiary of the ‘gig economy’ and the concomitant increase in demand for personnel background checks.

The flexibility of the labour market continues to expand and that is increasing the demand for ClearStar’s direct services and is providing new opportunities for revenue generation.

READ: Clearstar posts underlying profit as demand for medical screening climbs

In its half-year results statement, Bob Vale, ClearStar's chief executive, said the company was confident of achieving full year 2018 revenue growth in line with market expectations and being EBITDA (underlying earnings) positive.

Better still, the company expects to deliver accelerated revenue growth in 2019.

Revenue in the first six months of 2018 rose by 11% to US$9.9mln with medical turnover 27% higher at US$3.9mln.

House broker finnCap said the top-line was revising at a rate that was consistent with its full-year forecast.

Adjusted underlying earnings (EBITDA) was just about positive, at US$65,000, compared with a loss of US$165,000 in the first half of 2017.

“Good working capital control has left the net cash position unchanged over the half at US$1.2mln and we continue to expect this to see the company through to future profit and cash generation,” the broker added.

Top-line growth is being driven by medical information services

The company is experiencing growing demand for its technologically-differentiated solutions, particularly for medical information services. Additionally, in the direct services market, the company is receiving increased business from large corporates due to greater brand awareness resulting from investment in its sales & marketing efforts.

“Future growth will be assisted by the on-boarding of major new clients such as IntelliCentrics and MultiLatin, as well as the new global employment screening solution built around the Sphere platform and the new biometric services,” finnCap said.

ClearMD, the company’s mobile drug testing solution, is proving a big hit and is being integrated with eScreen’s offering.

Thanks to the company's integrations with LabCorp and Quest Diagnostics, ClearStar is now the only provider offering paperless medical screening with a fully-customisable user platform across all three of the major laboratories in the US – and the company expects to benefit from the economies of scale associated with engaging multiple large suppliers.

Growing the direct client base will propel ClearStar into the black

That quest for economies of scale was echoed by finnCap, which said the underlying drivers for the business are the continued “upscaling” of the direct client base in an improving US labour market; the increasing traction for its Sphere global offering in the worldwide market; the strength and opportunity in its medical testing business; and finally, the continued strong performance of the company’s original Channel Partner division.



View full CLSU profile View Profile

ClearStar Inc Timeline

Big Picture
October 02 2018

Related Articles

mobile phone user
September 20 2018
“We want to be in situation where we are processing the lion’s share of the biggest merchants’ digital business to mobile users”
Mergers & acquisitions - takeover
January 11 2018
"Vermeg's acquisition of Lombard Risk will create a leading global financial software provider," said Badreddine Ouali, founder and chairman of Vermeg
Top-level domains
October 12 2018
In its interims, management undertook a full review of historic legacy agreements that led to a final US$721,000 final restructuring payment made against one agreement and an onerous contract provision on another resulting in a one-time write down for future expected losses of US$7mln with an associated US$4.1mln reduction in intangible assets to US$81.5mln.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use